You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
英国葛兰素史克药厂季度收入逊预期 正推动业务分拆
阿思达克 04-29 09:54
英国葛兰素史克药厂(GlaxoSmithKline)公布首季业绩。季度纯利10.73亿英镑,按年跌31.4%。每股季度纯利21.5便士,经调整後为每股22.9便士,高於市场预测的21.9便士。季度收入74.18亿英镑,按年跌18%,低於市场预期的78.3亿英镑。

公司季绩受成本削减及新冠防疫放宽後关键治疗增加所推动,销售下跌则因为去年同期民众因应新冠储备药物。公司亦表示将於6月23日公布计划明年把非处方药业务,跟处方药和疫苗业务分拆的详情。

公司股价昨日(28日)跌不足0.1%,报1,336.6便士。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account